Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06665308 · ClinicalTrials.gov registry record
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
A clinical trial, sponsored by Sanofi.
- Completed
- Registry status
- 97
- Enrollment target
NCT06665308 is a clinical trial that has completed, run by Sanofi. The registered enrollment target is 97 participants.
The verdict
NCT06665308 has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
This is a multi-center, hospital based, cross-sectional study based on data from patient medical records, including laboratory results. The study will include adult patients with chronic (\> 1 year duration) primary Immune Thrombocytopenia (ITP) only. Patients will be identified based on a laboratory confirmed diagnosis of ITP in the medical records, where there is also a physician-confirmed diagnosis of primary ITP. If patients consent to take part in the study, a routine clinical visit will also serve as the study visit. Patients who do not have a routine visit scheduled during the study period but who would otherwise be eligible may be contacted by the site. In such cases, clinicians may use their discretion to schedule a visit specifically for study purposes. All study participants will have a routine blood test as part of their standard clinical care at the study visit, and this same procedure will be used to collect supplementary blood samples to assess a variety of biomarkers. Data will be collected using a combination of chart review, clinical outcome assessment administration, and laboratory results through blood tests.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2025-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06665308
The ClinicalTrials.gov registry entry for NCT06665308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT06665308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06665308 about?
NCT06665308 is a clinical study titled "Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)". This is a multi-center, hospital based, cross-sectional study based on data from patient medical records, including laboratory results. The study will include adult patients with chronic (\> 1 year duration) primary Immune Thrombocytopenia (ITP) only. Patients will be identified based on a laborator...
What is the current status of trial NCT06665308?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2025-01-13. Estimated completion is 2025-11-26.
What interventions are being tested in trial NCT06665308?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06665308?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.